Proto Labs shares have surged 53.6% over the past six months to a new 52-week high of $81.68, but analysts at StockStory remain cautious, citing three concerns. The company's revenue grew at a tepid 4.6% annualized rate over the last five years, while earnings per share declined 2.9% annually over the same period, indicating falling profitability. Its five-year average return on invested capital was negative 0.9%, among the worst in the industrials sector. With the stock now trading at 40.3 times forward earnings, the analysts believe better opportunities exist elsewhere.
Proto Labs IncAnalysts urge caution due to tepid revenue growth, declining EPS, negative ROIC, and high valuation.